The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

22 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Oxaspirol B with p97 Inhibitory Activity and Other Oxaspirols from Lecythophora sp. FL1375 and FL1031, Endolichenic Fungi Inhabiting Parmotrema tinctorum and Cladonia evansii.EBI
University of Arizona
Structure-Activity Study of Bioisosteric Trifluoromethyl and Pentafluorosulfanyl Indole Inhibitors of the AAA ATPase p97.EBI
University of Pittsburgh
Discovery of 2-(cyclohexylmethylamino)pyrimidines as a new class of reversible valosine containing protein inhibitors.EBI
Nerviano Medical Sciences
Alkylsulfanyl-1,2,4-triazoles, a new class of allosteric valosine containing protein inhibitors. Synthesis and structure-activity relationships.EBI
TBA
2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97).EBI
Kyowa Hakko Kogyo
Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of colorectal cancer.EBI
Nanjing Normal University
AAA ATPases as therapeutic targets: Structure, functions, and small-molecule inhibitors.EBI
California Institute of Technology
Discovery of novel pyrimidine molecules containing boronic acid as VCP/p97 Inhibitors.EBI
Nanjing Normal University
A covalent p97/VCP ATPase inhibitor can overcome resistance to CB-5083 and NMS-873 in colorectal cancer cells.EBI
California Institute of Technology
Allosteric Indole Amide Inhibitors of p97: Identification of a Novel Probe of the Ubiquitin Pathway.EBI
University of Pittsburgh
Discovery of Irreversible p97 Inhibitors.EBI
University of Minnesota
p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections.EBI
TBA
Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of non-small cell lung cancer.EBI
Nanjing Normal University
Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083).EBI
Cleave Biosciences
Optimization of Phenyl Indole Inhibitors of the AAA+ ATPase p97.EBI
University of Pittsburgh Chemical Diversity Center
ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A.EBI
University of Arizona